β¨ Medicines Consent and Government Notices
1340 NEW ZEALAND GAZETTE, No. 46 8 MAY 2014
- Sale or marketing of this medicine may only occur if:
β’ the sponsor has an appropriate blood monitoring and patient record database in place.
Note: This renewed consent is valid for two years from 3 June 2014.
Dated this 1st day of May 2014.
DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
go2747
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Demazin 12 Hour Relief Nasal Spray
Active Ingredient: Oxymetazoline hydrochloride 0.5mg/mL
Dosage Form: Nasal spray solution
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer: CPL Contract Pharmaceuticals Limited, Ontario, Canada
Product: Dimetapp Saline Nasal drops
Active Ingredient: Sodium chloride 7.04mg/mL
Dosage Form: Nasal drops
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: PSM Healthcare Limited trading as API Consumer Brands, Auckland, New Zealand
Product: Dimetapp Saline Nasal spray
Active Ingredient: Sodium chloride 7.04mg/mL
Dosage Form: Nasal spray solution
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: PSM Healthcare Limited trading as API Consumer Brands, Auckland, New Zealand
Product: Sudafed PE Phenylephrine Night
Active Ingredients:
Chlorphenamine maleate 2mg
Paracetamol 500mg
Phenylephrine hydrochloride 5mg equivalent to Phenylephrine 4.1mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Johnson & Johnson (New Zealand) Limited
Manufacturers: Johnson & Johnson Pty Limited, Cape Town, South Africa
Janssen-Cilag, Val de Reuil, France
Dated this 1st day of May 2014.
DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
go2745
Social Development # The Treasury
Social Security (Childcare Assistance) Regulations 2004 ## Crown Entities Act 2004
Notice of Suspension of Approval of an OSCAR Service ### Reappointment to the Government Superannuation Fund Authority Board
The Deputy Chief Executive, MSD Approvals, Ministry of Social Development, gives notice that the approval of Lavender House Limited as an OSCAR Service under clause 26 of the Social Security (Childcare Assistance) Regulations 2004 is suspended effective as of 17 April 2014.
Dated this 2nd day of May 2014.
MURRAY EDRIDGE, Deputy Chief Executive, MSD Approvals, Ministry of Social Development.
go2780
Pursuant to section 28 of the Crown Entities Act 2004, I reappoint
Keith Bruce Taylor
as a member and chair of the Government Superannuation Fund Authority Board from 1 May 2014 to 30 April 2017.
Dated at Wellington this 28th day of April 2014.
HON BILL ENGLISH, Minister of Finance.
go2698
Next Page →
β¨ LLM interpretation of page content
π₯
Consent for Distribution of Clozaril 100mg Tablets
(continued from previous page)
π₯ Health & Social Welfare1 May 2014
Medicines, Consent, Clozaril, Clozapine, Tablet
- DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare1 May 2014
Medicines, Consent, Nasal Spray, Nasal Drops, Tablet
- DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health
Suspension of Approval of an OSCAR Service
Social Development2 May 2014
OSCAR Service, Suspension, Childcare Assistance
- MURRAY EDRIDGE, Deputy Chief Executive, MSD Approvals, Ministry of Social Development
π° Reappointment to the Government Superannuation Fund Authority Board
π° Finance & Revenue28 April 2014
Reappointment, Government Superannuation Fund, Board
- Keith Bruce Taylor, Reappointed as member and chair
- HON BILL ENGLISH, Minister of Finance
NZ Gazette 2014, No 46